Arcam receives order from implant industry in Europe
ET | Source:Arcam AB
Arcam, listed on NASDAQ OMX, has received an order for an Arcam Q10 system from
an implant manufacturer in Europe.
”This is an order from a new customer in the implant industry. Our new EBM
system range, the Q-series, is well received and the Arcam Q10, designed for
implant manufacturing, helps us reach new customers”, says Magnus René, CEO of
The above information has been made public in accordance with the Securities
Market Act and/or the Financial Instruments Trading Act. The information was
published on February 11, 2014.
For further information please contact:
Magnus René, CEO Arcam AB
Tel: 46 31 710 32 00, alt. cell: 46 702 79 89 99, or e-mail:
Arcam provides a cost-efficient Additive Manufacturing solution for production
of metal components. The technology offers freedom in design combined with
excellent material properties and high productivity. Arcam’s market is global
with customers mainly in the orthopedic and aerospace industries. The company
was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office
and production facilities are located in Mölndal, Sweden. Support offices are
located in the US, UK, Italy and China.
Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.